Ansamycin antibiotic. Inhibits HSP90 and associated client proteins including v-Src, Bcr-Abl, Raf-1 and ErbB2. Reverts tyrosine kinase-induced oncogenic transformation without direct inhibition of phosphorylation activity. Inhibits angiogenesis in a rat retinopathy model
Know who made it. See the evidence. Buy through one marketplace.
Ansamycin antibiotic. Inhibits HSP90 and associated client proteins including v-Src, Bcr-Abl, Raf-1 and ErbB2. Reverts tyrosine kinase-induced oncogenic transformation without direct inhibition of phosphorylation activity. Inhibits angiogenesis in a rat retinopathy model
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
